Riley S McIvor

Professor, Genetics, Cell Biology and Development (TMED)
Leader, Administration (CBS)
Adjunct Professor, Laboratory Medicine and Pathology

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

28 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5 Active
28 Finished

Engineered B Cells as a Universal Platform for the Treatment of Enzymopathies
Moriarity, B. S., Lund, T. C., McIvor, R. S., Orchard, P. J. & Webber, B. R.
NIH Nat'l Inst of Allergy & Infect Dis
3/1/20 → 2/28/25
Project: Research project
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
McIvor, R. S.
B-MOGEN BIOTECHNOLOGIES INC
1/1/20 → 5/31/21
Project: Research project
Murine Studies of AAV Mediated Gene Therapy for Mucopolysaccharidosis
McIvor, R. S.
REGENXBIO Inc.
11/30/18 → 10/31/21
Project: Research project
Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis
McIvor, R. S. & Lund, T. C.
IMMUSOFT CORPORATION
9/5/18 → 8/31/21
Project: Research project
Inhibition of Opioid Tolerance
Fairbanks, C. A., Vulchanova, L., Wickman, K. D., Wilcox, G. L. & McIvor, R. S.
NIH NIDA NATL INST ON DRUG AB
6/1/14 → 5/31/21
Project: Research project

136 Article
7 Review article
3 Chapter
2 Comment/debate

Mucopolysaccharidosis type I: Current treatments, limitations and prospects for improvement
Hampe, C. S., Wesley, J., Lund, T. C., Orchard, P. J., Polgreen, L. E., Eisengart, J., McLoon, L. K., Cureoglu, S., Schachern, P. & McIvor, R. S., Feb 2021, In: Biomolecules. 11, 2, p. 1-25 25 p., 189.
Research output: Contribution to journal › Review article › peer-review

Open Access
Dysostosis Multiplex in Human Mucopolysaccharidosis Type 1 H and in Animal Models of the Disease
Hampe, C. S., Polgreen, L. E., Lund, T. C. & McIvor, R. S., Aug 1 2020, In: Pediatric endocrinology reviews : PER. 17, 4, p. 317-326 10 p.
Research output: Contribution to journal › Article › peer-review
Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
Belur, L. R., Podetz-Pedersen, K. M., Tran, T. A., Mesick, J. A., Singh, N. M., Riedl, M., Vulchanova, L., Kozarsky, K. F. & McIvor, R. S., Sep 2020, In: Molecular Genetics and Metabolism Reports. 24, 100604.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
Hampe, C. S., Eisengart, J. B., Lund, T. C., Orchard, P. J., Swietlicka, M., Wesley, J. & McIvor, R. S., Aug 5 2020, In: Cells. 9, 8
Research output: Contribution to journal › Review article › peer-review

Open Access
ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome
Ou, L., DeKelver, R. C., Rohde, M., Tom, S., Radeke, R., St. Martin, S. J., Santiago, Y., Sproul, S., Przybilla, M. J., Koniar, B. L., Podetz-Pedersen, K. M., Laoharawee, K., Cooksley, R. D., Meyer, K. E., Holmes, M. C., McIvor, R. S., Wechsler, T. & Whitley, C. B., Jan 2 2019, In: Molecular Therapy. 27, 1, p. 178-187 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
20 Scopus citations